Virtus ETF Advisers’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,777
| Closed | -$125K | – | 377 |
|
|
2021
Q3 | $125K | Sell |
5,777
-302
| -5% | -$6.54K | 0.06% | 368 |
|
|
2021
Q2 | $213K | Buy |
6,079
+3,935
| +184% | +$138K | 0.09% | 297 |
|
|
2021
Q1 | $211K | Buy |
2,144
+38
| +2% | +$3.74K | 0.09% | 318 |
|
|
2020
Q4 | $228K | Buy |
2,106
+660
| +46% | +$71.5K | 0.09% | 331 |
|
|
2020
Q3 | $149K | Sell |
1,446
-197
| -12% | -$20.3K | 0.08% | 314 |
|
|
2020
Q2 | $343K | Sell |
1,643
-1,768
| -52% | -$369K | 0.16% | 271 |
|
|
2020
Q1 | $333K | Sell |
3,411
-497
| -13% | -$48.5K | 0.14% | 215 |
|
|
2019
Q4 | $450K | Buy |
3,908
+1,573
| +67% | +$181K | 0.07% | 219 |
|
|
2019
Q3 | $127K | Sell |
2,335
-130
| -5% | -$7.07K | 0.03% | 280 |
|
|
2019
Q2 | $293K | Buy |
+2,465
| New | +$293K | 0.06% | 225 |
|
|
2018
Q4 | – | Sell |
-8,300
| Closed | -$502K | – | 305 |
|
|
2018
Q3 | $502K | Sell |
8,300
-6,095
| -42% | -$369K | 0.05% | 119 |
|
|
2018
Q2 | $763K | Buy |
+14,395
| New | +$763K | 0.67% | 60 |
|